Farnesyltransferase inhibition overcomes the adaptive resistance to targeted therapies in oncogene-addicted non-small cell lung cancer II
RNA-seq (gene expression) · human · 44 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Lung cancerThis series is part of our curated briefing on it.
- Samples
- 44 samples: 14 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapiesNature communications · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE249721_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1050239 and SRA study SRP476773. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 40 samples.
How we read this: 14 replicated groups read from 44 sample titles; they account for 40 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7961962 H3255_Erlo_21j_1 H3255_Erlo_21j
- GSM7961963 H3255_Erlo_21j_2 H3255_Erlo_21j
- GSM7961964 H3255_Erlo_21j_3 H3255_Erlo_21j
- GSM7961965 H3255_Erlo_24h_1 H3255_Erlo_24h
- GSM7961966 H3255_Erlo_24h_2 H3255_Erlo_24h
- GSM7961967 H3255_NT1 H3255_NT
- GSM7961968 H3255_NT2 H3255_NT
- GSM7961969 H3255_NT3 H3255_NT
- GSM7961970 H4006_CT_24h_1 H4006_CT_24h
- GSM7961971 H4006_CT_24h_2 H4006_CT_24h
- GSM7961972 H4006_CT_24h_3 H4006_CT_24h
- GSM7961973 H4006_Erlo_24h_1 H4006_Erlo_24h
- GSM7961974 H4006_Erlo_24h_2 H4006_Erlo_24h
- GSM7961975 H4006_Erlo_24h_3 H4006_Erlo_24h
- GSM7961976 H4006_Erlo_DTC_1 H4006_Erlo_DTC
- GSM7961977 H4006_Erlo_DTC_2 H4006_Erlo_DTC
- GSM7961978 H4006_Erlo_DTC_3 H4006_Erlo_DTC
- GSM7961979 H4006_Erlo_DTEC_1 H4006_Erlo_DTEC
- GSM7961980 H4006_Erlo_DTEC_2 H4006_Erlo_DTEC
- GSM7961981 H4006_Erlo_DTEC_3 H4006_Erlo_DTEC
- GSM7961982 HCC827Osimertinib11d1 HCC827Osimertinib11d
- GSM7961983 HCC827Osimertinib11d2 HCC827Osimertinib11d
- GSM7961984 HCC827Osimertinib11d3 HCC827Osimertinib11d
- GSM7961985 HCC827Untreated1 HCC827Untreated
- GSM7961986 HCC827Untreated2 HCC827Untreated
- GSM7961987 HCC827Untreated3 HCC827Untreated
- GSM7961988 PC9_3_DTEC_A_75_jours
- GSM7961989 PC9_3_DTEC_B_75_jours
- GSM7961990 PC9_3_DTEC_D_75_jours
- GSM7961991 PC9_3_DTEC_E_75_jours
- GSM7961992 PC9_3_NT1_1 PC9_3_NT1
- GSM7961993 PC9_3_NT1_2 PC9_3_NT1
- GSM7961994 PC9_CT_24h_1 PC9_CT_24h
- GSM7961995 PC9_CT_24h_2 PC9_CT_24h
- GSM7961996 PC9_CT_24h_3 PC9_CT_24h
- GSM7961997 PC9_Erlo_24h_1 PC9_Erlo_24h
- GSM7961998 PC9_Erlo_24h_2 PC9_Erlo_24h
- GSM7961999 PC9_Erlo_24h_3 PC9_Erlo_24h
- GSM7962000 PC9_Erlo_DTC_1 PC9_Erlo_DTC
- GSM7962001 PC9_Erlo_DTC_2 PC9_Erlo_DTC
+ 4 more — browse all 44 samples with per-sample file links →
- GSE241518 High-throughout sequencing of colorectal cancer and non-small cell lung cancer cells treated actived compound YHM18 4 samples same disease briefing · shares non-small
- GSE114761 Transforming Growth Factor β-Induced Epithelial-to-Mesenchymal Signature Predicts Metastasis-Free Survival in Non-Small Cell Lung Cancer. 42 samples same disease briefing · shares non-small
- GSE127465 Single cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species 40 samples same disease briefing
- GSE103550 Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 24 samples same disease briefing
- GSE117570 Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 8 samples same disease briefing
- GSE10072 Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival 107 samples same disease briefing
- GSE17958 Affymetrix SNP array data for 47 lung squamous cell carcinoma and 40 esophageal squamous cell carcinoma samples. 87 samples same disease briefing
- GSE104244 Bone Marrow Derived Macrophages, NSCLC cell lines, and Kras G12D Lung Tumors Treated with Epigenetic Agents 33 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.